MedTrace Logo

Tolerance of Healthy Term Infants Fed Infant Formulas #4

NCT01155414 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2011-11-01

No results posted yet for this study

Summary

The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.

Conditions

  • Healthy Term Infants

Interventions

OTHER

Hydrolysate based infant formula

Infant formula ad lib

OTHER

Investigational Infant Formula A

Investigational infant formula ad lib

OTHER

Investigational Infant Formula B

Investigational infant formula ad lib

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Marlene Borschel, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155414 on ClinicalTrials.gov